期刊文献+

乳腺癌与多原发恶性肿瘤 被引量:14

Breast Cancer Associated with Multiple Primary Malignant Neoplasms
暂未订购
导出
摘要 目的 :探讨乳腺癌在MPMNs中的地位。方法 :回顾性分析 195 8年~ 1997年收治的 398例乳腺癌伴MPMNs。结果 :1)双原发乳腺癌发生率为 2 5 % ,发病年龄 41岁 ,间隔时间 5 4年。 5、10、2 0年生存率分别为86 6 %、5 7 7%和 2 5 8%。 2 )同一乳腺PD伴乳腺癌发病率为 0 9% ,高发年龄为 47 3岁。 5、10、2 0年生存率为 :6 4 7%、5 0 %和 2 0 6 %。 3)乳腺癌伴其他脏器癌瘤的MPMNs发生率为 3 6 % ,高发年龄 49 4岁 ,间隔时间为 8 6年。好发器官为肺、子宫、食管、卵巢和大肠。 4)乳腺癌作为第二、三原发癌的MPMNs发生率 2 3% ,年龄 5 0 1岁 ,间隔时间 7 1年 ;第一原发癌好发器官为 :子宫、大肠、卵巢和食管。结论 :1)乳腺是MPMNs的主要受累器官。2 )乳腺癌伴发MPMNs中易受累的器官为 :女性激素的靶器官 (乳腺、子宫、卵巢 )和乳腺癌放疗区域的器官 (肺和食管 )。 3)正确诊断和治疗可得到较好的治疗效果。 Objective: To study the role of breast cancer in multiple primary malignant neoplasms (MPMNs) Methods: Three hundred and ninety-eight cases of breast cancer associated with MPMNs were analysed retrospectively Results: 1) The incidence rate of primary bilateral breast cancers was 2 5%with the morbidity age of 41 years, intermitting time between the two malignancies was 5 4 years The 5-,10-and 20-year survival rates were 86 6%, 57 7%and 25 8%respectively 2) The incidence rate of Paget′s disease associated with breast cancer was 0 9%with a high incident age of 47 3 years and 5-, 10-and 20-year survival rates of 64 7%, 50%and 20 6%respectively 3) The incidence rate of breast cancer associated with MPMNs of other organs was 3 6%with the peak incident age of 49 4 years, intermitting time of 8 6 years and the organs commonly involved were lung, uterus, esophagus, ovary and large intestine 4) The incidence rate of breast cancer as the second or third primary malignancy associated with MPMNs was 2 3%with the high morbidity age of 50 1 years, intermitting time 7 1 years and the commonly involved organs were uterus, large intestine, ovary and esophagus Conclusion: 1) Breast was the main organ of MPMNs 2) The predilection organs of MPMNs of breast cancer were the target organs of female hormone (breast, ovary and uterus) and the organs in the radiative area of breast cancer (lung and esophagus) 3) Correct diagnosis and treatment strategy of the disease can get better results
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2000年第5期349-351,共3页 Chinese Journal of Clinical Oncology
关键词 多原发恶性肿瘤 乳腺癌 同时性 异时性 诊断 Multiple primary malignant neoplasms Breast cancer Synchronous Metachronous Diagnosis Treatment
  • 相关文献

参考文献8

  • 11,Ozer E,Canda T,Kuyucuodlu F. P53 mutations in bilateral breast carcinoma.Correlation with Ki- 67 expression and the mean nuclear volume. Cancer letters,1998;122(1- 2):101~ 6
  • 22,Rovatti M,Gerosa E,Turi V,et al. Multiple Primary malignant neoplasms. Minerva chir,1995;50(11):909~ 58
  • 33,Awad AT,el- Husseini G,Anwar M,et al. Bilateral primary breast cancer:a Clinicopathological study of the second primary. Int Surg,1996;81(1):57~ 60
  • 44,Suris- Swartz PJ,Schillkraut JM,Vine MF,et al. Age at diagnosis and multiple Primary cancer of the breast and ovary. Breast Cancer Res and Treat,1996;41(1):21~ 9
  • 55,Osther PJ,Balslev E,Blichert- Toft M. Paget′ s disease of the nipple,A continuing enigma. Acta Chir Scand,1990;156(5):343~ 52
  • 66,Kollmorgen DR,Varanasi JS,Edge SB,et al. Paget′ s disease of the breast:a 33- year experience. J Am Coll Surg,1998;187(2):171~ 7
  • 77,Palade R,Vasidescu D,Grigoriu M. Paget′ s disease of breast- a special form of breast cancer. Chir,1995;44(4):21~ 7
  • 88,Saarela AO,Rissanen TJ,Kiviniemi HO,et al. Mammographic and ultrosonographic findings in bilateral breast cancer,a comparative study. Eur Radio,1998;8(4):634~ 8

同被引文献86

  • 1Feng Jiao,Hai Hu,Li-Wei Wang.Quadruple primary malignancy patient with survival time more than 20 years[J].World Journal of Gastroenterology,2013,19(9):1498-1501. 被引量:8
  • 2周卫兵,冯炎.放疗的致癌作用[J].中华放射肿瘤学杂志,2005,14(4):370-372. 被引量:13
  • 3李威,詹友庆,李国辉.双原发癌156例临床分析[J].中华肿瘤杂志,1996,18(4):296-298. 被引量:73
  • 4孙开宇,付青兰,王乐强,郭桂芳,刘长山.肺肿瘤与雌激素关系及治疗探讨[J].现代肿瘤医学,2007,15(3):352-354. 被引量:2
  • 5王建设,章龙珍.23例重复癌临床分析[J].徐州医学院学报,2007,27(6):383-386. 被引量:12
  • 6沈志祥 陈志术.抗瘤治疗引起的第二肿瘤.肿瘤,1993,13(6):274-276.
  • 7Thomas GA. Solid cancers after therapeutic radiation : can we predict which patients are most at risk[ J] .9 Clin Oncol (R Coil Radiol), 2004,16 ( 6 ) :429-434.
  • 8Kay SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated therapy [J]. Int J Radiat Oncol Biol Phys, 2005,62(3) :1195-1203.
  • 9Schneider U, Zwahlen D, Ross D, et al. Estimation of radiationinduced cancer from three-dimensional dose distributions;concept of organ equivalent dose [ J ]. Int J Radiat Oncol Biol Phys, 2005,62(5 ) : 1510-1515.
  • 10Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region[J]. Radiother Oncol, 1999,53( 1 ) :199-203.

引证文献14

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部